About aganirsen
Antisense oligonucleotide eye medicine
Used for
- Investigated for corneal blood-vessel growth associated with severe eye disease; not an established routine treatment.
Usual adult dose
No approved standard dose; studied as eye drops in clinical trials.
Common side effects
- Eye irritation or discomfort may occur.
Important warnings
- Aganirsen is investigational and is not an established approved treatment.
- Clinical-trial evidence and safety information are limited.
Pregnancy
Insufficient information to establish safety during pregnancy.
Breastfeeding
Insufficient information to establish safety during breastfeeding.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.